Article Versions Notes

Basappa B, Jung YY, Ravish A, Xi Z, Swamynayaka A, Madegowda M, Pandey V, Lobie PE, Sethi G, Ahn KS. Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells. Biomedicines. 2023; 11(6):1662. https://doi.org/10.3390/biomedicines11061662

Basappa, Basappa, Young Yun Jung, Akshay Ravish, Zhang Xi, Ananda Swamynayaka, Mahendra Madegowda, Vijay Pandey, Peter E. Lobie, Gautam Sethi, and Kwang Seok Ahn. 2023. "Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells" Biomedicines 11, no. 6: 1662. https://doi.org/10.3390/biomedicines11061662

Basappa, B., Jung, Y. Y., Ravish, A., Xi, Z., Swamynayaka, A., Madegowda, M., Pandey, V., Lobie, P. E., Sethi, G., & Ahn, K. S. (2023). Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells. Biomedicines, 11(6), 1662. https://doi.org/10.3390/biomedicines11061662